Is there a generic for Rubidium chloride rb-82?

The FDA Orange Book does not currently list an approved generic (ANDA) for Rubidium chloride rb-82. It is available as 2 brand (NDA) applications.

What is the reference-listed drug for Rubidium chloride rb-82?

RUBY-FILL (NDA 202153, JUBILANT) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Rubidium chloride rb-82 are approved?

Rubidium chloride rb-82 is approved in the following dosage forms: injectable, solution.

FDA Orange Book · active-ingredient family

Rubidium chloride rb-82

Rubidium chloride rb-82 is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:RUBY-FILL · NDA 202153

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable, solution

Product	Applicant	Application	TE	Approved
RUBY-FILL	JUBILANT	NDA 202153	—	Sep 30, 2016
CARDIOGEN-82	BRACCO	NDA 019414	—	Dec 29, 1989

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Rubidium chloride rb-82 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo